CD8A and neoplasm: This molecule is expressed in activated CD4+ and CD8+ T-cells, natural killer (NK) cells, B cells, tumour-associated macrophages (TAM), dendritic cells, and monocytes, interacting with the ligand present in antigen-presenting cells (APC) and tumour cells (TC) [22,25,30].